Bill Sponsor
House Bill 3253
116th Congress(2019-2020)
Sustaining Excellence in Medicaid Act of 2019
Became Law
Amendments
Became Law
Became Public Law 116-39 on Aug 6, 2019
Overview
Text
Introduced
Jun 13, 2019
Latest Action
Aug 6, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3253
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Michigan
Democrat
California
Democrat
Massachusetts
Republican
Michigan
Republican
Michigan
Democrat
New Jersey
House Votes (1)
Senate Votes (1)
checkPassed on June 19, 2019
Question
On Motion to Suspend the Rules and Pass, as Amended
Status
Passed
Type
Roll Call Vote
Roll Call Vote
A vote that records the individual position of each Member who voted. Such votes occurring on the House floor (by the "yeas and nays" or by "recorded vote") are taken by electronic device. The Senate has no electronic voting system; in such votes, Senators answer "yea" or "nay" as the clerk calls each name aloud. Each vote is compiled by clerks and receives a roll call number (referenced in Congress.gov as a "Record Vote" [Senate] or "Roll no." [House]).
Roll Call Type
2/3 Yea-And-Nay
Roll Number
333
House Roll Call Votes
Summary

Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act of 2019

This bill alters several Medicaid programs and funding mechanisms. Specifically, the bill

  • makes appropriations through FY2024 for, and otherwise revises, the Money Follows the Person Rebalancing Demonstration Program;
  • allows state Medicaid fraud control units to review complaints regarding patients who are in noninstitutional or other settings;
  • temporarily extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home and community-based services;
  • temporarily extends the Medicaid demonstration program for certified community behavioral health clinics;
  • repeals the requirement, under the Medicaid Drug Rebate Program, that drug manufacturers include the prices of certain authorized generic drugs when determining the average manufacturer price (AMP) of brand-name drugs (also known as a "blended AMP"), and excludes manufacturers from the definition of "wholesalers" for purposes of rebate calculations; and
  • increases funding available to the Medicaid Improvement Fund beginning in FY2021.
Amendments (1)
Jul 25, 2019
Agreed to in Senate
1
Sponsorship
Senate Amendment 930
In the nature of a substitute.
Agreed To
Public Record
Record Updated
Nov 1, 2022 1:51:05 PM